T.Man Pharmaceutical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,506	2,213	1,972	2,017	1,260
Other Revenue	19.94	13.35	7.81	8.05	3.43
Revenue	2,526	2,226	1,980	2,025	1,263
Revenue Growth (YoY)	13.48%	12.42%	-2.20%	60.26%	40.25%
Cost of Revenue	1,338	1,133	1,003	923.57	861.26
Gross Profit	1,188	1,093	976.84	1,101	402.08
Selling, General & Admin	597.11	546.65	496.43	452.32	313.35
Operating Expenses	603.04	543.35	451.8	492.88	321.07
Operating Income	584.79	549.98	525.04	608.21	81.01
Interest Expense	-28.44	-18.63	-14.85	-16.98	-7.18
EBT Excluding Unusual Items	556.35	531.36	510.19	591.23	73.83
Other Unusual Items	-107.06	-	-	-	-
Pretax Income	613.81	531.36	510.19	591.23	73.83
Income Tax Expense	90.74	80.65	79.1	118.71	17.44
Earnings From Continuing Operations	523.07	450.7	431.09	472.52	56.39
Minority Interest in Earnings	-0	-0	-0	-	-
Net Income	523.07	450.7	431.09	472.52	56.39
Net Income to Common	523.07	450.7	431.09	472.52	56.39
Net Income Growth	16.06%	4.55%	-8.77%	737.91%	-5.84%
Shares Outstanding (Basic)	400	343	275	250	72
Shares Outstanding (Diluted)	400	343	275	250	72
Shares Change (YoY)	16.47%	24.68%	10.30%	246.21%	8.20%
EPS (Basic)	1.31	1.31	1.56	1.89	0.78
EPS (Diluted)	1.31	1.31	1.56	1.89	0.78
EPS Growth	-0.35%	-16.14%	-17.29%	142.02%	-12.98%
Free Cash Flow	110	345.71	62.15	289.02	196.49
Free Cash Flow Per Share	0.28	1.01	0.23	1.16	2.72
Dividend Per Share	0.320	0.200	0.036	-	-
Dividend Growth	60.00%	455.56%	-	-	-
Gross Margin	47.02%	49.12%	49.33%	54.38%	31.83%
Operating Margin	23.15%	24.71%	26.52%	30.04%	6.41%
Profit Margin	20.71%	20.25%	21.77%	23.34%	4.46%
Free Cash Flow Margin	4.35%	15.53%	3.14%	14.27%	15.55%
EBITDA	700.72	645.11	611.56	678.68	148.29
EBITDA Margin	27.74%	28.98%	30.89%	33.52%	11.74%
D&A For EBITDA	115.93	95.12	86.52	70.48	67.28
EBIT	584.79	549.98	525.04	608.21	81.01
EBIT Margin	23.15%	24.71%	26.52%	30.04%	6.41%
Effective Tax Rate	14.78%	15.18%	15.50%	20.08%	23.62%
Revenue as Reported	2,691	2,226	1,980	2,025	1,263
Advertising Expenses	101	113	97	89	52

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.